Taken together, our data indicate the complex TSP-4/integrin α2/HSF1/TGF-β cascade mediates reciprocal interactions between GBC cells and CAFs, providing a promising therapeutic target for gallbladder cancer patients. The gene discussed is TGFB1; the disease is gallbladder cancer.